< Back to Article
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
Table 1
Baseline characteristics of the study population (n = 519).
EPA: RPV/TDF/FTC group.
doi: https://doi.org/10.1371/journal.pone.0155842.t001